Skip to main content

Saint Louis University School of Medicine Header Logo Center

Menu Search & Directory

Current Vaccine Studies

Healthy volunteers of all ages, races, and genders are needed to continue vaccine development at the Saint Louis University Center for Vaccine Development.

Participation in a vaccine study is voluntary and confidential. All study vaccines and tests are free of charge and volunteers receive compensation for time and travel.

Tuberculosis Study (18-55 years old)

Tuberculosis (TB) is an infectious disease caused by a bacteria (germ) called Mycobacterium tuberculosis (Mtb). People who are sick with TB can spread the germs from one person to another and TB can often cause death. There are medicines that can treat and cure TB disease.  However, strains of Mtb are becoming increasingly resistant to anti-TB medicines.  The only approved and currently licensed vaccine is “BCG”.  It is given to babies in some parts of the world but provides incomplete or only partial protection against TB infection and disease, so there is a great need for a more effective vaccine. 

Key Points

  •   To participate, you MUST be between 18 and 55  years old

  •  Participation is strictly voluntary

  • You will be compensated for participating $75 per visit and $10 per phone call

  •  There are about 9 visits and 1 phone call over approximately 14 months

For more information about the study, please contact the Vaccine Center at 314-977-6333 or 1-866-410-6333 (toll-free) and refer to Study #328 IRB #29609

Avian (Bird) Flu Study (18-64 years old)

In April 2013, an outbreak of a new avian (bird) influenza A virus, the H7N9 virus, was reported in China. The H7N9 virus was also found in poultry (for example, chickens and ducks) in those areas. Many of the people infected with the H7N9 virus reported contact with live poultry. Since that time, new avian influenza H7N9 viruses have appeared and continue to change and circulate in China, causing about 1,500 infections in humans.

The recent years the rise in cases of bird flu strains in human populations in other parts of the world has increased efforts to be prepared in case of widespread infection.  A key to a successful plan is vaccine production. 

 The purpose of this study is to research the safety and efficacy of an experimental vaccine developed to protect against the bird flu virus H7N9. 

 Key Points

  • To participate, you must be 18 to 64 years old

  •  You cannot get the bird flu from the vaccine

  •  Participation is strictly voluntary

Payment and Time Commitment

  • You will be compensated for participating: $75 per visit.
  • Your total participation will be up to13 months
  • There could be up to six clinic visits and five phone calls

To discuss volunteering, please contact a nurse at 1-866-410-6333 (toll free) or at and refer to study #327 or IRB # 29587.